Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1987-01-12
1990-12-18
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 78, 424 78, A61K 3170, A61K 31685
Patent
active
049786547
ABSTRACT:
A method is disclosed for treatment of disseminated fungal infection in a mammal comprising the administration of a fungicidally effective amount of Amphotericin B encapsulated in a substantially sterol-free liposome to the infected mammal. Also provided is an agent for treatment of disseminated fungal infection in a mammal comprising Amphotericin B encapsulated in a liposome which consists essentially of lipids other than sterols.
REFERENCES:
patent: 4186183 (1980-01-01), Steck et al.
patent: 4235871 (1980-11-01), Papahadjopoulos
patent: 4330534 (1982-05-01), Sakurai et al.
Juliano, Rudy et al. "Pharmacokinetic and Theraputic Consequences of Liposomal Drug Delivery: Fluorodeoxyuridine and Amphotericin B as Examples", vol. 47, Biologie Cellulaire, May 1983, pp. 39-46.
Lopez-Berestein et al., "Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mie with Liposome-Encapsulated Amphotericin B", vol. 147, No. 5, The Journal of Infectious Diseases, May 1983, pp. 989-945.
Lopez-Berestein et al. "Effects of Sterols on the Therapeutic Efficacy of Liposomal Amphotericin B in Murine Candidiasis", vol. 1, No. 1, Cancer Drug Delivery, 1983, pp. 37-42.
Hopfer, R. L., "In Vitro Antifungal Activities of Amphotericin B and Liposome-Encapsulated Amphotericin B", vol. 25, No. 3, Anti-microbial Agents and Chemotherapy, Mar. 1984, pp. 387-389.
Mehta, R. et al., "Liposomal Amphotericin B is Toxic to Fungal Cells but not to Mammalian Cells", Biochimica et Biophysica Acta 770 (1984) pp. 230-234.
Lopez-Berestein, G. et al.. "Altered Tissue Distribution of Amphotericin B by Liposomal Encapsulation: Comparison of Normal Mice to Mice Infected with Candida albicans", vol. 1, No. 3, Cancer Drug Delivery, Jun. 1984, pp. 199-205.
Lopez-Berestein, G. et al., "Prophylaxis of Candida albicans Infection in Neutropenic Mice with Liposome-Encapsulated Amphoterin B", vol. 25, No. 3, Antimicrobial Agents and Chemotherapy Mar. 1984.
Lopez-Berestein et al., "Treatment with Liposome-Encapsulated Amphotericin B of Dessiminated Candidiasis in Neutropenic Mice", Journal of Infectious Diseases, Aug. 1984.
Graybill, John R. et al., "Treatment of Murine Crptococcosis with Liposome-Associated Amphotericin B", vol. 145, No. 5, The Journal of Infectious Diseases, May 1982, pp. 748-752.
Taylor, Robert L., "Amphotericin B in Liposomes: A Novel Therapy for Histoplasmosis".
Szoka, Francis Jr. et al., "Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes)", Ann. Rev. Biophys. Bioeng., 1980, pp. 467-508.
Tom, Baldwin H., "An Overview: Liposomes and Immunology--Macrophages, Liposomes, and Tailored Immunity", 1980, Liposomes and Immunobiology, pp. 3-19.
Magee, Wayne E. et al., "A Comparison of Negatively and Positively Charged Liposomes Containing Entrapped Polyinosinic Polycytidylic Acid for Interferon Induction in Mice", 451, Biochimica et Biophysica Acta, 1976, pp. 610-618.
Graybill ICAAC Abstract, 1982, p. 152.
Tremblay ICAAC Abstract, 1983, p. 222.
Barza ICAAC Abstract, 1983, p. 133.
Fungizone, Product Information, Physician's Desk Reference 1983, p. 1929.
HsuChen, Chemical Abstract, vol. 79, 1973 28102g, p. 119.
HsuChen, Chemical Abstract, vol. 80, 1974 23178e, pp. 80-81.
Chen, Chemical Abstract, vol. 87, 1977, 163184y, p. 177.
Sheridan, Chemical Abstract, vol. 87, 1977 195913b, p. 254.
Van Hoogevest, Chemical Abstract, vol. 89, 1978 157215j, p. 23.
Sokolov, Chemical Abstract, vol. 90, 1979 163615b, p. 179.
Boudet, Chemical Abstract, vol. 91, 1979 102345n, p. 80.
Nakamura, Chemical Abstract, vol. 92, 1980, 176122e, p. 208.
Bolard, Chemical Abstract, vol. 93, 1980, 127554j, p. 234.
Takamura, Chemical Abstract, vol. 95, 1981, 161822w, p. 33.
New, Chemical Abstract, vol. 96, 1982, 57652a, p. 360.
Liberman, Chemical Abstract, vol. 78, 1973, 53407e, pp. 106-107.
Kasumov, Chemical Abstract, vol. 79, 1973, 27977s, p. 108.
Gent, Chemical Abstract, vol. 84, 1976, 100974y, p. 185.
Moore, Chemical Abstract, vol. 84, 1976, 146551m, p. 205.
Asher, Chemical Abstract, vol. 87, 1977, 80067m, p. 193.
Schiffman, Chemical Abstract, vol. 87, 1977, 193716r, p. 40.
Borisova, Chemical Abstract, vol. 90, 1979, 82569n, p. 206.
Ohki, Chemical Abstract, vol. 91, 1979, 104067x, p. 251.
Oku, Chemical Abstract, vol. 92, 1980, 123748g, pp. 248-249.
Teerlink, Chemical Abstract, vol. 93, 1980, 142742n, p. 32.
Oehlschlager, Chemical Abstract, vol. 93, 1980, 198021u, p. 85.
Yamaguchi, Chemical Abstract, vol. 93, 1980, 198503c, p. 141.
Babunashvili, Chemical Abstract, vol. 95, 1981, 37636z, p. 272.
Deleers, Chemical Abstract, Vol. 95, 1981, 182480y, p. 219.
Bolard, Chemical Abstract, vol. 96, 1982, 2252q, p. 202.
Aggett, Chemical Abstract, vol. 96, 1982, 81472n, p. 225.
Fainstein Victor
Hersh Evan M.
Hopfer Roy L.
Juliano Rudolph L.
Lopez-Berestein Gabriel
Board of Regents , The University of Texas System
Rollins John W.
LandOfFree
Composition and method for treatment of disseminated fungal infe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for treatment of disseminated fungal infe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treatment of disseminated fungal infe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1425721